PURPOSE: Sentinel node biopsy (SNB) has been shown to accurately stage the regional lymphatics in oral carcinoma. However, intraoperative pathology is only moderately sensitive and final pathology takes several days to complete. The purpose of this study was to develop a rapid, automated, and quantitative real-time PCR (qRT-PCR) assay that can match final pathology in an intraoperative time frame. EXPERIMENTAL DESIGN: Four hundred forty-eight grossly tumor-negative lymph nodes were evaluated for expression of 3 markers [PVA (pemphigus vulgaris antigen), PTHrP (parathyroid hormone-related protein), and TACSTD1 (tumor-associated calcium signal transducer 1)]. Conformity of metastasis detection by qRT-PCR was determined using hematoxylin and eosin and immunohistochemistry staining as the gold standard. PVA and TACSTD1 were then multiplexed with β-glucuronidase to develop a rapid, automated single-tube qRT-PCR assay using the Cepheid GeneXpert system. This assay was used to analyze 103 lymph nodes in an intraoperative time frame. RESULTS: Four hundred forty-two nodes produced an informative result for both qRT-PCR and pathologic examination. Concordance of qRT-PCR for individual markers with final pathology ranged from 93% to 98%. The best marker combination was TACSTD1 and PVA. A rapid, multiplex assay for TACSTD1 and PVA was developed on the Cepheid GeneXpert and demonstrated an excellent reproducibility and linearity. Analysis of 103 lymph nodes demonstrated 94.2% accuracy of this assay for identifying positive and negative nodes. The average time for each assay to yield results was 35 minutes. CONCLUSIONS: A rapid, automated qRT-PCR assay can detect lymph node metastasis in head and neck cancer with high accuracy compared to pathologic analysis and may be more accurate than intraoperative pathology. Combined, SNB and rapid qRT-PCR could more appropriately guide surgical treatment of patients with head and neck cancer.
PURPOSE: Sentinel node biopsy (SNB) has been shown to accurately stage the regional lymphatics in oral carcinoma. However, intraoperative pathology is only moderately sensitive and final pathology takes several days to complete. The purpose of this study was to develop a rapid, automated, and quantitative real-time PCR (qRT-PCR) assay that can match final pathology in an intraoperative time frame. EXPERIMENTAL DESIGN: Four hundred forty-eight grossly tumor-negative lymph nodes were evaluated for expression of 3 markers [PVA (pemphigus vulgaris antigen), PTHrP (parathyroid hormone-related protein), and TACSTD1 (tumor-associated calcium signal transducer 1)]. Conformity of metastasis detection by qRT-PCR was determined using hematoxylin and eosin and immunohistochemistry staining as the gold standard. PVA and TACSTD1 were then multiplexed with β-glucuronidase to develop a rapid, automated single-tube qRT-PCR assay using the Cepheid GeneXpert system. This assay was used to analyze 103 lymph nodes in an intraoperative time frame. RESULTS: Four hundred forty-two nodes produced an informative result for both qRT-PCR and pathologic examination. Concordance of qRT-PCR for individual markers with final pathology ranged from 93% to 98%. The best marker combination was TACSTD1 and PVA. A rapid, multiplex assay for TACSTD1 and PVA was developed on the Cepheid GeneXpert and demonstrated an excellent reproducibility and linearity. Analysis of 103 lymph nodes demonstrated 94.2% accuracy of this assay for identifying positive and negative nodes. The average time for each assay to yield results was 35 minutes. CONCLUSIONS: A rapid, automated qRT-PCR assay can detect lymph node metastasis in head and neck cancer with high accuracy compared to pathologic analysis and may be more accurate than intraoperative pathology. Combined, SNB and rapid qRT-PCR could more appropriately guide surgical treatment of patients with head and neck cancer.
Authors: Siva Raja; Talal El-Hefnawy; Lori A Kelly; Melissa L Chestney; James D Luketich; Tony E Godfrey Journal: Clin Chem Date: 2002-08 Impact factor: 8.327
Authors: Steven J Hughes; Liqiang Xi; Siva Raja; William Gooding; David J Cole; William E Gillanders; Keidi Mikhitarian; Kenneth McCarty; Susan Silver; Jesus Ching; William McMillan; James D Luketich; Tony E Godfrey Journal: Ann Surg Date: 2006-03 Impact factor: 12.969
Authors: Francisco J Civantos; Carmen Gomez; Carlos Duque; Felipe Pedroso; William Jarrard Goodwin; Donald T Weed; David Arnold; Fred Moffat Journal: Head Neck Date: 2003-01 Impact factor: 3.147
Authors: Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2012-09-15 Impact factor: 2.503
Authors: Naoki Umemura; Jianzhong Zhu; Yvonne K Mburu; Adriana Forero; Paishiun N Hsieh; Ravikumar Muthuswamy; Pawel Kalinski; Robert L Ferris; Saumendra N Sarkar Journal: Cancer Res Date: 2011-11-04 Impact factor: 12.701
Authors: Vyomesh Patel; Daniel Martin; Ruchika Malhotra; Christina A Marsh; Colleen L Doçi; Timothy D Veenstra; Cherie-Ann O Nathan; Uttam K Sinha; Bhuvanesh Singh; Alfredo A Molinolo; James F Rusling; J Silvio Gutkind Journal: Oral Oncol Date: 2012-09-23 Impact factor: 5.337
Authors: Jack Wadden; Brandon S Newell; Joshua Bugbee; Vishal John; Amy K Bruzek; Robert P Dickson; Carl Koschmann; David Blaauw; Satish Narayanasamy; Reetuparna Das Journal: Commun Biol Date: 2022-07-15
Authors: Robert L Ferris; Michael T Lotze; Stanley P L Leong; David S B Hoon; Donald L Morton Journal: Clin Exp Metastasis Date: 2012-08-01 Impact factor: 5.150